missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ AGO1/AGO2 Polyclonal Antibody

Description
AGO1/AGO2 Polyclonal Antibody for Western Blot, ELISA
IEF2C1 and 2 are members of the Argonaute family. These proteins are involved in short-interfering-RNA-mediated gene silencing. This process is mediated by the RISC (RNA induced silencing complex), a multicomponent nuclease that is able to degrade double stranded RNAs. The mRNA degradation is triggered by the association of specific siRNAs with their homologous mRNAs. IEF2C2 has been shown to be essential for embryonic development.
Spécification
Spécification
| Antigène | AGO1/AGO2 |
| Applications | ELISA, Western Blot |
| Classification | Polyclonal |
| Concentration | Conc. Not Determined |
| Conjugué | Unconjugated |
| Formule | Whole serum with 0.05% sodium azide |
| Expression | AGO2 |
| Numéro d’ordre du gène | Q9UKV8, Q9UL18 |
| Alias de gène | AGO1; AGO2; argonaute 1; argonaute 1, RISC catalytic component; argonaute 2; argonaute 2, RISC catalytic component; argonaute RISC catalytic component 1; Argonaute RISC catalytic component 2; argonaute1; Argonaute2; CTA-204B4.6; EIF2C; eIF2C 1; eIF-2C 1; eIF2C 2; eIF-2C 2; EIF2C1; EIF2C2; Eukaryotic translation initiation factor 2C 1; Eukaryotic translation initiation factor 2C 2; eukaryotic translation initiation factor 2C, 1; eukaryotic translation initiation factor 2C, 2; GERP95; Golgi Endoplasmic Reticulum protein 95 kDa; hAgo1; hAgo2; PAZ Piwi domain protein; PPD; protein argonaute-1; Protein argonaute-2; protein slicer; Putative RNA-binding protein Q99; Q10; Q99 |
| Symboles de gène(s) | AGO1, AGO2 |
| Afficher plus |
Nom du produit
En cliquant sur Soumettre, vous reconnaissez que vous pouvez être contacté par Fisher Scientific au sujet des informations que vous avez fournies dans ce formulaire. Nous ne partagerons pas vos informations à d'autres fins. Toutes les informations de contact fournies seront également conservées conformément à notre politique de confidentialité. Politique de confidentialité.
Vous avez repéré une opportunité d'amélioration ?